ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
1
views
0
references
Top references
cited by
4
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
6,495
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod.
Author(s):
Timothy Tully
1
,
Alastair Barkley
1
,
Eli Silber
2
Publication date
(Electronic):
May 12 2015
Journal:
Neurology
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Karger: Neurology and Neuroscience
Author and article information
Journal
Journal ID (iso-abbrev):
Neurology
Title:
Neurology
Publisher:
Ovid Technologies (Wolters Kluwer Health)
ISSN (Electronic):
1526-632X
ISSN (Print):
0028-3878
Publication date (Electronic):
May 12 2015
Volume
: 84
Issue
: 19
Affiliations
[
1
]
From Kings College Hospital London, UK.
[
2
]
From Kings College Hospital London, UK. eli.silber@nhs.net.
Article
Publisher Item ID:
WNL.0000000000001556
DOI:
10.1212/WNL.0000000000001556
PubMed ID:
25878178
SO-VID:
017a1415-4ed3-4620-8fce-5eb734d55649
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
6,495
Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis
Authors:
M Fernández-Arquero
,
J.B.A. Crusius
,
J.A. Campillo
…
A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of daclizumab HYP monotherapy in relapsing-remitting multiple sclerosis: primary results of the SELECT trial
Authors:
G Giovannoni
,
R Gold
,
K Selmaj
Transplantation of umbilical cord and bone marrow-derived mesenchymal stem cells in a patient with relapsing-remitting multiple sclerosis.
Authors:
Zong-liu Hou
,
Ying Liu
,
Xi-Hong Mao
…
See all similar
Cited by
4
Infectious Complications of Multiple Sclerosis Therapies: Implications for Screening, Prophylaxis, and Management
Authors:
David Epstein
,
Jeffrey Dunn
,
Stan Deresinski
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis
Authors:
Alberto Gajofatto
,
Marco Turatti
,
Salvatore Monaco
…
A comprehensive review of varicella-zoster virus, herpes simplex virus and cryptococcal infections associated with sphingosine-1-phosphate receptor modulators in multiple sclerosis patients.
Authors:
Kanika Sharma
,
Durgesh P. Chaudhary
,
Katherine Beard
…
See all cited by